Frank
Sellrie
*a,
Michael
Beck†
b,
Niko
Hildebrandt
c and
Burkhard
Micheel
d
aUP Transfer GmbH—Hybrotec, c/o Fraunhofer Institute for Biomedical Engineering, Am Mühlenberg 13, D-14476, Potsdam-Golm, Germany. E-mail: frank.sellrie@up-transfer.de
bPhysical Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, D-14476, Potsdam-Golm, Germany
cNanoPolyPhotonics, Fraunhofer Institute for Applied Polymer Research, Geiselbergstr. 69, D-14476, Potsdam-Golm, Germany
dDepartment of Biotechnology, Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, D-14476, Potsdam-Golm, Germany
First published on 22nd July 2010
The determination of low-molecular weight substances (haptens) is demonstrated with a homogeneous time-resolved immunoassay using antibody-induced luminescence quenching. Our novel assay technology uses the newly developed monoclonal antibody (G24-BA9) to quench the luminescence of europium trisbipyridine (EuTBP). We performed a competitive biotin immunoassay including an EuTBP–biotin conjugate, the anti-EuTBP antibody G24-BA9 and streptavidin as assay components. Steric hindrance allows only the binding of either G24-BA9 (to the EuTBP moiety) or streptavidin (to the biotin moiety) to the EuTBP–biotin conjugate. Addition of the analyte biotin resulted in the binding of streptavidin to biotin and a concomitant preferred binding of G24-BA9 to EuTBP–biotin. Since G24-BA9 quenches the luminescence of EuTBP within the conjugate, the luminescence signal could be used to indicate and quantify the presence of free biotin in the system. All experiments were carried out in solution in the presence of 5% serum demonstrating the possibility of using our novel assay for a very fast determination of low molecular weight substances in biological fluids.
Fluorescence offers several possibilities to establish sensitive homogeneous immunoassays.1 Polarisation of light emitted by fluorescent dyes,2 Förster resonance energy transfer (FRET) between two different fluorescent dyes3–5 and fluorescence quenching by antibodies6 have been used for such assays.
A typical direct fluorescence quenching immunoassay uses an anti-analyte antibody, an analyte–fluorophore conjugate and the competing free analyte.7,8 Since in the conjugate the fluorophore and the analyte are in very close proximity binding of the anti-analyte antibody results in quenching of the fluorescence of the fluorophore. Another approach uses antibody binding for quenching FRET within analyte–fluorophore thus increasing the fluorophore fluorescence intensity.9,10 Another type of fluorescence quenching immunoassay designated indirect quenching fluoroimmunoassay or fluorescence protection immunoassay implies the basic principle of the experiments presented here.11,12 This type of assay uses an analyte–fluorophore conjugate together with two antibodies, one reactive to the analyte and the other binding and quenching the fluorophore. Due to steric hindrance, simultaneous binding of both antibodies to the conjugate is not possible so that the addition of free analyte changes the equilibrium of the system and hence also changes the fluorescence of the fluorophore in the conjugate.
We applied such an assay type for the determination of the herbicide diuron using fluorescein as fluorophore and the anti-fluorescein antibody B13-DE1 as quencher.13 Fluorescein is, however, not suitable as indicator for the determination of substances in biological fluids as its fluorescence is quenched by high protein concentration and is also spoiled by autofluorescence background signals.
Lanthanide complexes of europium (Eu3+) and terbium (Tb3+) ions are advantageous fluorescent markers for immunoassays since their long luminescence decay times (up to milliseconds) allow a time-gated fluorescence measurement and therefore an efficient discrimination from the short-lived autofluorescence background.14,15
Herein, we describe the determination of biotin in an indirect time-resolved fluorescence quenching immunoassay using a europium trisbipyridine (EuTBP) cryptate16–18 conjugated to biotin as indicator, streptavidin as biotin binder and an anti-EuTBP monoclonal antibody (G24-BA9) as quencher. The assay is very fast and sensitive and avoids the problems occurring when fluorescein is used as fluorescent moiety.
1 µl biotin–NHS containing 7 mg ml−1 was added to 1 µl containing 1 mg ml−1 EuTBP-NH2. The reaction was carried out in carbonate/bicarbonate buffer (50 mM, pH 9) at room temperature for 3 hours.
The resulting EuTBP–biotin conjugate (molecular weight presumably 1380 Da if both NH2 groups were conjugated) is presented in Fig. 1. It was used in all experiments without further purification.
![]() | ||
Fig. 2 Luminescence quenching of EuTBP–biotin induced by the binding of the monoclonal EuTBP-binding antibody G24-BA9 to the conjugate. The assay mixture consisted of EuTBP–biotin conjugate (final dilution 1![]() ![]() ![]() |
A homogeneous indirect luminescence quenching immunoassay for the determination of biotin could be developed on the basis of this effect. The assay system consisted of an EuTBP–biotin conjugate (Fig. 1), the quenching antibody G24-BA9 and the biotin binder streptavidin. The indicator molecule EuTBP–biotin can be bound either by antibody G24-BA9 or by streptavidin. Due to steric hindrance, simultaneous binding of both molecules to the conjugate is not possible. Free biotin in the mixture should result in the binding by streptavidin so that more anti-EuTBP antibody can bind to the conjugate. Since G24-BA9 quenches the luminescence of EuTBP in the conjugate a diminished luminescence signal can be used as an indicator for the presence of the analyte biotin. The interaction between the assay components and the analyte and the resulting luminescence are schematically shown in Fig. 3.
![]() | ||
Fig. 3 Schematic presentation of the homogeneous luminescence quenching immunoassay. A homogeneous immunoassay was established for the determination of the hapten analyte biotin. (a) The assay system contains a conjugate in which the analyte biotin (B) is chemically linked to the luminophore EuTBP (Eu) and two different binding molecules, one specific for the analyte (streptavidin—SAv) and the other for the luminophore (antibody G24-BA9—Ab). The proximity of B and Eu in the conjugate permits the binding of only one binding molecule at a time. (b) Since Ab quenches the luminescence of Eu, the steric hindrance can be utilized to demonstrate free B added to the system. Addition of free B reduces the amount of conjugate-bound SAv and increases the amount of conjugate-bound Ab, which induces the luminescence quenching. The decreasing luminescence intensity is therefore a quantitative indicator of free analyte present in the test sample. |
The assay system was successfully applied to the determination of biotin. Increasing analyte concentrations resulted in decreasing luminescence values as expected. A concentration of 18.1 ng ml−1 biotin led to a 50% reduction in the luminescence signal in our model experiment (Fig. 4).
![]() | ||
Fig. 4 Application of the homogeneous luminescence quenching immunoassay for the determination of the vitamin biotin. The assay mixture consisted of an EuTBP–biotin conjugate (final dilution 1![]() ![]() ![]() |
The main advantage of this assay is the very short evaluation time since it does not depend on any long-time incubation or separation steps. The assay was carried out in the presence of 5% newborn calf serum which had obviously no negative effects on the results. Higher protein concentrations are generally unfavourable for most fluorescence assay applications.13 A successful application of our novel assay principle was possible because of the utilization of time-resolved luminescence detection which easily discriminates the assay signals from short-lived autofluorescence background signals.
The assay should allow the determination of biotin (vitamin H) in different tissue and food samples.22 For the determination and quantification of biotin in serum the detection limit of the assay has to be improved by a factor of 10 to detect concentrations in a range of 0.2 to 1 ng ml−1.23 This problem can possibly be solved by purifying the conjugate which presumably still contains free unconjugated biotin which may disturb the assay and impairs the sensitivity.
One other problem affecting the assay sensitivity might be related to the fact that streptavidin is capable of binding four biotin molecules. This could in principle lower the sensitivity by a factor of four. It is otherwise probably responsible for a cross-linking between streptavidin and EuTBP–biotin (as one conjugate molecule consists of two biotin molecules). The concentrations used in the experiments are too low to observe any visible effects like precipitation or turbidity. A cross-linking would increase the steric hindrance of antibody binding and therefore even improve the assay sensitivity. Experiments confirming these assumptions were not carried out.
After reaching a better sensitivity this assay could be the most favourable test for the determination of biotin especially because of its simple sample handling and very fast evaluation time compared to the biotin determinations applied so far.24
Our homogeneous assay should also be applicable for the determination of other low molecular weight substances. For this purpose monoclonal antibodies have to be selected binding to the corresponding analyte and competing with the anti-EuTBP antibody for binding to the analyte–EuTBP conjugate. The big advantage is that only one new antibody needs to be selected because the anti-EuTBP antibody can be used for all different assays.
Due to the necessity of steric hindrance it is much more difficult to apply this assay type to the determination of high-molecular weight substances. However, Nargessi et al.11 and Zuk et al.12 demonstrated that steric hindrance of antibodies in binding to the surface of fluorophore-labeled proteins can be used in some cases to generate homogeneous immunoassays. Another approach could be the use of peptides in the luminophore conjugates representing linear or mimotope25,26 epitopes of the corresponding proteins.
The selection of the necessary antibodies requires, however, considerable efforts. Investigations for evaluating the feasibility of these approaches towards the determination of proteins with our assay system are in progress.
Footnote |
† Current address: Einstein-Gymnasium, Haydnstr. 3, D-77694 Kehl, Germany |
This journal is © The Royal Society of Chemistry 2010 |